Yield10 Bioscience Inc (YTEN)
OTC PINK OTC PINK Primary Summary
Yield10 Bioscience Announces Adjournment of Special Meeting of Stockholders to Solicit Sufficient Votes in Favor of the Key Proposals
Special Meeting Adjourned to Thursday, November 21, 2024 WOBURN, MA / ACCESSWIRE / November 8, 2024 / Yield10 Bioscience, Inc. (OTCQB:YTEN) ("Yield10" or the "Company"), an agricultural bioscience company, today announced that its Special Meeting of Stockholders (the "Special Meeting"), scheduled to be held at 11:00 a.m., Eastern Time, on November 8, 2024, was convened and adjourned, without any business being conducted, due to lack of sufficient votes in favor of the key proposals related to the Asset Sale to Nuseed and the Dissolution proposal.
Yield10 Bioscience Inc Profile
| - Industry | - Sector | Dr. Oliver P. Peoples Ph.D. CEO | OTC PINK Exchange | US98585K8624 ISIN |
| United States Country | 29 Employees | - Last Dividend | 16 Jan 2020 Last Split | 10 Nov 2006 IPO Date |
Overview
Yield10 Bioscience, Inc. is an agricultural bioscience company that leverages the potential of Camelina oilseeds to develop products aimed at enhancing agricultural productivity and sustainability. The company is dedicated to commercializing innovative solutions that address the demand for nutritional oils and eco-friendly biofuel feedstocks. Originally known as Metabolix, Inc., the company underwent a rebranding to Yield10 Bioscience, Inc. in January 2017, marking a strategic shift towards agricultural bioscience. With its incorporation in 1992 and headquarters in Woburn, Massachusetts, Yield10 Bioscience has established itself as a key player in the field of agricultural bioscience, particularly in the United States. Its focus on using advanced biotechnology to improve crop yield and composition underscores its commitment to addressing global challenges related to food security and sustainability.
Products and Services
List of products and services offered by Yield10 Bioscience, Inc:
- Camelina Oil for Omega-3 Fatty Acids Production: This product leverages the Camelina oilseed's unique properties to produce high levels of omega-3 fatty acids, specifically eicosapentanoic acid (EPA) and docosahexanoic acid (DHA). These fatty acids are crucial for human health, offering benefits such as reducing inflammation and improving heart health. Yield10 Bioscience's approach not only enhances the nutritional value of Camelina oil but also supports sustainable agricultural practices by providing an alternative source of these essential nutrients.
- Low-Carbon Intensity Feedstock Oil for Biofuels: Yield10 Bioscience has also developed a use for Camelina oil as a low-carbon intensity feedstock oil for the production of biofuels. This includes biodiesel, renewable diesel (RD), and sustainable aviation fuel (SAF). By focusing on the development of environmentally friendly biofuels, Yield10 Bioscience contributes to the reduction of greenhouse gas emissions and supports the transition towards more sustainable energy sources. This initiative aligns with global efforts to combat climate change and promotes the use of renewable resources over fossil fuels.
Contact Information
